The available studies assessing BRCA1 and 2 promoter methylation in breast cancer have predominantly analyzed primary breast tumors with only one recent study by Bonnet et al. showing BRCA1 promotor hypermethylation in 4% of metastatic TNBC samples [14]. This evidence concerns the gene BRCA1 and breast carcinoma.